If you’re male and over 25, you’ve likely seen a ton of ads for hair loss products. There’s a war raging between the likes of Hims (aka ForHims.com), Roman (aka getroman.com), and Keeps (keeps.com), ...

Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...

The company that once focused on discreet issues like hair loss and ED is now leaning into full-spectrum wellness — from nutrient testing to longevity. Dudum says diagnostic capabilities will ...

Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the company’s forecast came in below estimates, and looming worries about the ...

Hims & Hers Health has become one of the most popular growth stocks in the market today. After sharing with my readers a bullish perspective on the stock at ~$6/share in 2023, I'm back to provide a ...